In: Seminars in Immunopathology, 2015, vol. 37, no. 2, p. 173-186
|
In: European Journal of Clinical Microbiology & Infectious Diseases, 2015, vol. 34, no. 10, p. 2049-2055
|
In: Cellular and Molecular Life Sciences, 2015, vol. 72, no. 8, p. 1463-1471
|
In: European Journal of Clinical Microbiology & Infectious Diseases, 2015, vol. 34, no. 9, p. 1849-1857
|
In: The Journal of Infectious Diseases, 2016, vol. 213, no. 9, p. 1370-1379
|
In: Current Infectious Disease Reports, 2015, vol. 17, no. 6, p. 1-5
|
In: Seminars in Immunopathology, 2015, vol. 37, no. 2, p. 83-96
|
In: Microbial Ecology, 2015, vol. 70, no. 1, p. 51-60
|
In: Antimicrobial Agents and Chemotherapy, 2017, vol. 61, no. 4, p. -
Antipyretics are some of the most commonly used drugs. Since they are often coadministered with antimicrobial therapy, it is important to understand the interactions between these two classes of drugs. Our review is the first to summarize the antimicrobial effects of antipyretic drugs and the underlying mechanisms involved. Antipyretics can inhibit virus replication, inhibit or promote...
|
In: PLoS pathogens, 2015, vol. 11, no. 10, p. e1005164
Candida spp. can cause severe and chronic mucocutaneous and systemic infections in immunocompromised individuals. Protection from mucocutaneous candidiasis depends on T helper cells, in particular those secreting IL-17. The events regulating T cell activation and differentiation toward effector fates in response to fungal invasion in different tissues are poorly understood. Here we generated...
|